
USC Schaeffer Center co-director testifies at U.S. Senate hearing
Erin Trish testified about pharmacy benefit managers before the Committee on Commerce, Science and Transportation.
Erin Trish testified about pharmacy benefit managers before the Committee on Commerce, Science and Transportation.
The USC team’s study showed that an informational letter from the county medical examiner reduced the number of opioid prescriptions clinicians wrote.
Health experts see abortion as a public health issue — but in politics, it’s a campaign issue and this is a critical election year.
Growing evidence suggests that U.S. consumers overpay for generics by as much as 20% while pharmacy benefit managers pad profits, a USC Schaeffer Center white paper finds.
A USC expert on medicine access, drug utilization and pharmaceutical policy weighs in on what’s at stake across the country.
USC Schaeffer Center Senior Fellow Rosalie Liccardo Pacula warns of potential impact to public health.
USC Schaeffer study tracks down the insulin pricing and distribution chain.
Ginsburg, a senior fellow at the USC Schaeffer Center and professor of practice at USC Price, was recognized for his role in shaping and influencing health policy.
Opioid-related deaths among Blacks, Asians and Latinos dropped during the same period, according to a study from USC and the L.A. County Medical Examiner-Coroner’s Office.
With racial and socioeconomic inequality come inequities in well-being.
While Congress considers proposals for federal drug liberalization including legalizing marijuana and decriminalization, Rosalie Liccardo Pacula is working to inform decisions regarding possible regulations through research.
Private sector influence plus a market demand for mandates will likely overcome state laws that have limited vaccine requirements thus far, a USC study finds.
Intermediaries are negotiating good drug prices but lack the incentives to pass savings to beneficiaries and taxpayers, a USC study finds.
A lack of affordable housing and the resulting crowded apartments play a major role in L.A. County’s nearly 1.2 million confirmed coronavirus cases, USC experts say.
Despite insulin’s importance to these patients, increases in out-of-pocket spending were associated with reduced drug adherence, USC research finds.
Eliminating surprise medical bills offers the potential to lower health insurance premiums across the board, say three USC health economists and policy analysts.
USC research shows how several major countries could prepare their health systems to ensure patients can get Alzheimer’s treatments once they hit the market.
USC Schaeffer Center researchers are heading up the American Life in Real-time initiative, which will collect data from across all socio-demographic groups in an attempt to lessen systemic inequity.
Treatments for COVID-19 would deliver up to $106 billion in gains by the end of 2021, a new analysis from the USC Schaeffer Center finds.
The Physician-Citizen-Scholar curriculum will be implemented in fall 2021 with the Class of 2025.
Countries with large vulnerable populations especially benefited from moving quickly, USC experts find.
As the world confronts a pandemic, the World Health Organization finds itself under a storm of criticism. A USC health policy expert asks: To what extent can we say the agency did not provide adequate information?
A visiting scholar at the USC Schaeffer Center envisions a certification system that would allow people who’ve recovered from COVID-19 to begin jump-starting the economy.
Some states issued stay-at-home measures earlier than others. Has it made a difference? Here’s what USC Schaeffer Center experts say.